Paranasal Sinus Cancer Market Share, Potential Growth, Demand And Analysis Of Key Players- Research Forecasts To 2028
Paranasal Sinus Cancer Market
Market Overview
Market Research Future (MRFR) estimates the global paranasal
sinus cancer market to garner a CAGR of 5.2% during the assessment period of
2018–2023.
Paranasal sinus cancer is an extremely rare case of cancer
in which cells of the paranasal sinuses and nasal cavity develop malignancy.
Dust and certain chemical agents in the air can cause paranasal sinuses cancer.
Increase in air pollution and growing prevalence of chronic disease among
people can spur the risk of developing paranasal sinuses cancer. These factors
can fuel the paranasal
sinus cancer market. The rise in geriatric population is another factor
identified to boost the market growth. According to the American Cancer
Society, 4 out of 5 paranasal sinus cancer cases are of atleast 55 years
old. Collaboration strategies can have
powerful impact on the market growth. For example, in 2018, development and
marketing of digital clinical decision support solutions, was the outcome of G
E Healthcare’s partnership with Roche Diagnostics. In June 2018, ARMO
Biosciences was taken over by Eli Lilly for USD 1.6 billion for expanding its
oncology portfolio that backed support for its oncology portfolio. Hence, these
instances demonstrate that collaborations can create immense scope for new
innovation. Therefore, new product launches is a significant cause that can bolster
the paranasal sinus cancer market growth.
Expensive treatment for paranasal sinus cancer and strict
rules governing new product approval are certain causes which can restraint the
market growth.
Get Sample Report: https://www.marketresearchfuture.com/sample_request/7514
Segments Analysis
MRFR’s segmental analysis of the paranasal sinus cancer
offers a comprehensive insight into the market that allows our esteemed clients
to develop growth strategies, identifying new scope for the market expansion.
The global paranasal sinus cancer market study has been segmented into
diagnosis, treatment, and end user.
Based on the diagnosis, the market study has been segmented
into physical examination, imaging tests, biopsy, medical history, and others.
The imaging tests segment has been further classified into X-rays, CT scan, MRI
scan, and PET scan. The biopsy segment is sub-segmented into fine needle
aspiration (FNA) biopsy, and incisional and excisional biopsies.
Based on the treatment, the market study has been segmented
into radiotherapy, surgery, and chemotherapy.
Based on the end user, the market study has been segmented
into hospitals and clinics, research laboratories, cancer treatment and
research centers, and others.
Key Players
Important companies operating in the market are AbbVie,
Inc., Pfizer Inc., Eli Lilly & Company, Novartis AG, Ipsen
Biopharmaceuticals Inc, G E Healthcare, Agilent Technologies Inc., AstraZeneca,
Boehringer Ingelheim International GmbH,
Bristol-Myers Squibb Company, F. Hoffman-La Roche Ltd., Abbott, Becton,
Dickinson & Company, Thermo Fisher Scientific, and Bayer AG.
Access Report Details @ https://www.marketresearchfuture.com/reports/paranasal-sinus-cancer-market-7514
Regional Insights
A vivid understanding of the regional paranasal sinus cancer
market activities can be derived from the regional analysis of the market.
Based on the region, the market has been segmented into America, Europe, Asia
Pacific, and the Middle East.
The North American paranasal sinus cancer market is expected
to be at the forefront owing to the increase in rare cancer and chronic disease
cases in the region. Excellent medical infrastructure and increase in medical
expenses are other factors which can amplify the regional market growth.
Increase in cases of people suffering from chronic diseases,
government funding, and firm medical infrastructure in Europe, the paranasal
sinus cancer market is anticipated to exhibit a robust growth, securing the
second largest market size in the near future.
Government in the Asia Pacific region are keen in taking
initiatives to improve healthcare facilities which is predicted as a major
cause that can propel the regional market. hike in disposable income and
growing prevalence of chronic diseases are other factors which can fuel the
regional paranasal sinus cancer market growth.
MRFR predicts that the paranasal sinus cancer market in the
Middle East Asia and Africa is expected to exhibit static market growth.
At Market Research Future (MRFR), we enable our customers
to unravel the complexity of various industries through our Cooked Research
Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
Contact:
Market Research Future®
99 Hudson Street,5Th Floor
New York, New York 10013
United States of America
Phone:
+1 628 258 0071(US)
+44 2035 002 764(UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
Comments
Post a Comment